Viewing nowPioglitazone Tablets 30 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

MFDS item code 202003844 · Approved 2020.05.26 · Insurance code 646005160
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be administered alone while following dietary and exercise regimens and can also be combined with other hypoglycemic agents such as sulfonylureas, metformin, or insulin if effective alone. Additionally, nutritional counseling, weight loss, and continued exercise therapy are necessary to better maintain the effectiveness of medication treatment. This medication helps improve blood sugar levels in patients with type 2 diabetes.
This medication is administered orally once daily, regardless of meals. For monotherapy, start with 15 mg once daily. If the effect is insufficient, the dose may be increased to 30 mg once daily. For combination therapy with a sulfonylurea, metformin, or insulin, administer 15 mg once daily. The maximum recommended dose should not exceed 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this population.
This medication is used in the treatment of type 2 diabetes and works to improve insulin resistance. When taking this medication, there is a risk of heart failure occurring or worsening, so weight changes, breathing difficulties, swelling, and other symptoms should be closely monitored. Patients with heart failure or a history of heart failure should not use this medication, and if symptoms of heart failure appear, a doctor should be consulted immediately. This medication can cause fluid retention, which may lead to swelling; therefore, if swelling symptoms arise, medical staff should be informed. Additionally, this medication is not administered to patients with a history of bladder cancer or currently active bladder cancer. It is also safe not to use this medication in cases of poor liver function or severe renal impairment. Women who are pregnant or may become pregnant should not use this medication, and women who are premenopausal should exercise appropriate contraception during treatment as there may be an increased chance of becoming pregnant while taking this medication. There is a risk of hypoglycemia, so when combined with insulin or other hypoglycemic agents, one should be cautious for symptoms of hypoglycemia, and dosage adjustment of other medications may be necessary. Routine liver function tests should be conducted while using this medication, and if symptoms of liver dysfunction arise, medical staff should be informed immediately. If sudden weight gain, swelling, or shortness of breath occurs during treatment, consult a physician immediately. Elderly patients or those with renal function impairment require even more careful monitoring during treatment with this medication. In the case of overdose, even in the absence of specific symptoms, contact a medical institution immediately to receive appropriate treatment. This medication may interact with certain drugs, so be sure to inform medical staff of any other medications being taken. Finally, this medication has not established safety or efficacy in children, so it is not to be used in this population.
Congestive heart failure, excessive and rapid weight changes, dyspnea, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, swelling, abdominal distension, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular predisposition, hospitalization due to worsening congestive heart failure, emergency room visit due to congestive heart failure, liver failure, diabetic macular edema accompanied by vision loss, elevated serum ALT levels, decreased hemoglobin, elevated serum creatine kinase, gross hematuria, urinary disorders, urgency, fractures, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, dyspnea, itching, chest discomfort, tremors, chills, gastrointestinal disease, epigastric discomfort, numbness, muscle rigidity, head discomfort, worsening liver disease, hives, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, heart failure
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that does not allow light and air to enter, and should be kept away from humid places. The optimal storage temperature is 25 degrees Celsius, and it can be safely stored between 15 and 30 degrees Celsius.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.